Manufacturer Release 052
Guidance for : Several weeks ago many labelers received reports showing NDCs that were included on the MDRI master file, but not on the FDA master listed/pending files. Those affected labelers were instructed to contact the FDA in order to have those NDCs (on the report) that represented �drug� products properly listed (with the FDA) and to be prepared to have those NDCs (that were on the report) that represented �non-drug� products removed from the MDRI master file.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: September 19, 2001
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.